TSS
AZN icon

Two Sigma Securities’s AstraZeneca AZN Stock Holding History

Two Sigma Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,750
Closed -$2.14M – 2855
2024
Q2 		$2.14M Sell
13,750
-15,550
-53% -$2.34M 0.03% 684
2024
Q1 		$3.97M Buy
29,300
+600
+2% +$79.5K 0.04% 476
2023
Q4 		$3.87M Buy
28,700
+3,400
+13% +$442K 0.04% 449
2023
Q3 		$3.43M Buy
25,300
+23,850
+1,645% +$3.26M 0.04% 482
2023
Q2 		$208K Sell
1,450
-8,300
-85% -$1.22M ﹤0.01% 2193
2023
Q1 		$1.35M Buy
9,750
+5,150
+112% +$693K 0.03% 687
2022
Q4 		$624K Buy
+4,600
New +$577K 0.02% 943
2021
Q4 		– Sell
-10,300
Closed -$1.24M – 1543
2021
Q3 		$1.24M Buy
10,300
+1,600
+18% +$186K 0.04% 425
2021
Q2 		$1.04M Buy
+8,700
New +$955K 0.03% 396
2021
Q1 		– Sell
-62,350
Closed -$6.23M – 877
2020
Q4 		$6.23M Buy
62,350
+59,450
+2,050% +$6.3M 0.15% 80
2020
Q3 		$318K Buy
+2,900
New +$323K 0.01% 827
2020
Q1 		– Sell
-6,100
Closed -$608K – 1377
2019
Q4 		$608K Buy
6,100
+1,750
+40% +$165K ﹤0.01% 1331
2019
Q3 		$388K Buy
4,350
+1,300
+43% +$113K ﹤0.01% 1375
2019
Q2 		$252K Buy
+3,050
New +$239K ﹤0.01% 1561
2019
Q1 		– Sell
-7,200
Closed -$547K – 1826
2018
Q4 		$547K Sell
7,200
-19,150
-73% -$1.5M 0.01% 947
2018
Q3 		$2.08M Sell
26,350
-39,500
-60% -$2.99M 0.01% 695
2018
Q2 		$4.62M Buy
65,850
+13,100
+25% +$942K 0.02% 519
2018
Q1 		$3.69M Buy
52,750
+49,400
+1,475% +$3.42M 0.02% 594
2017
Q4 		$232K Buy
+3,350
New +$226K 0.01% 1191

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Two Sigma Securities's AZN Position: Q1 2026 in Review

Two Sigma Securities opened a new position in AstraZeneca (AZN) in Q1 2026: 3,201 shares worth $631K. The stake represents 0.07% of the portfolio and ranks #382 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in AZN as recently as Q4 2024.

Two Sigma Securities first reported a position in AZN in Q1 2018 and has held it in 20 quarters since. The position peaked at $13.3M in Q3 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Two Sigma Securities held 3,201 shares of AstraZeneca worth $631K as of Q1 2026.
  • AstraZeneca was a new Two Sigma Securities position in Q1 2026.
  • AstraZeneca made up 0.07% of Two Sigma Securities's portfolio in Q1 2026, its #382 holding.
  • Two Sigma Securities first reported a position in AstraZeneca in Q1 2018 and has held it in 20 quarters since.
  • Two Sigma Securities's AstraZeneca position peaked at $13.3M in Q3 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.